MNKD
Price
$7.00
Change
+$0.16 (+2.34%)
Updated
Dec 23, 04:59 PM (EDT)
71 days until earnings call
PLX
Price
$1.75
Change
-$0.01 (-0.57%)
Updated
Dec 23, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

MNKD vs PLX

Header iconMNKD vs PLX Comparison
Open Charts MNKD vs PLXBanner chart's image
MannKind
Price$7.00
Change+$0.16 (+2.34%)
Volume$120.4K
CapitalizationN/A
Protalix BioTherapeutics
Price$1.75
Change-$0.01 (-0.57%)
Volume$1.2K
CapitalizationN/A
MNKD vs PLX Comparison Chart
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNKD vs. PLX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a Hold and PLX is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (MNKD: $6.85 vs. PLX: $1.76)
Brand notoriety: MNKD and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 248% vs. PLX: 91%
Market capitalization -- MNKD: $1.89B vs. PLX: $129.6M
MNKD [@Biotechnology] is valued at $1.89B. PLX’s [@Biotechnology] market capitalization is $129.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 1 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 1 green, 4 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 6 TA indicator(s) are bullish while PLX’s TA Score has 4 bullish TA indicator(s).

  • MNKD’s TA Score: 6 bullish, 3 bearish.
  • PLX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than PLX.

Price Growth

MNKD (@Biotechnology) experienced а +4.74% price change this week, while PLX (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.12%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was +3.33%.

Reported Earning Dates

MNKD is expected to report earnings on Mar 04, 2025.

PLX is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-2.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.89B) has a higher market cap than PLX($130M). MNKD has higher P/E ratio than PLX: MNKD (85.63) vs PLX (13.00). MNKD YTD gains are higher at: 88.187 vs. PLX (-1.124). MNKD has higher annual earnings (EBITDA): 68.8M vs. PLX (-6.48M). MNKD has more cash in the bank: 252M vs. PLX (27.4M). PLX has less debt than MNKD: PLX (5.68M) vs MNKD (240M). MNKD has higher revenues than PLX: MNKD (267M) vs PLX (45.7M).
MNKDPLXMNKD / PLX
Capitalization1.89B130M1,453%
EBITDA68.8M-6.48M-1,063%
Gain YTD88.187-1.124-7,849%
P/E Ratio85.6313.00659%
Revenue267M45.7M584%
Total Cash252M27.4M920%
Total Debt240M5.68M4,222%
FUNDAMENTALS RATINGS
MNKD vs PLX: Fundamental Ratings
MNKD
PLX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
18100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
4038
P/E GROWTH RATING
1..100
8199
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLX's Valuation (62) in the Servicestothe Health Industry industry is in the same range as MNKD (75) in the Biotechnology industry. This means that PLX’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Profit vs Risk Rating (18) in the Biotechnology industry is significantly better than the same rating for PLX (100) in the Servicestothe Health Industry industry. This means that MNKD’s stock grew significantly faster than PLX’s over the last 12 months.

PLX's SMR Rating (95) in the Servicestothe Health Industry industry is in the same range as MNKD (100) in the Biotechnology industry. This means that PLX’s stock grew similarly to MNKD’s over the last 12 months.

PLX's Price Growth Rating (38) in the Servicestothe Health Industry industry is in the same range as MNKD (40) in the Biotechnology industry. This means that PLX’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's P/E Growth Rating (81) in the Biotechnology industry is in the same range as PLX (99) in the Servicestothe Health Industry industry. This means that MNKD’s stock grew similarly to PLX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNKDPLX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Ad is loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRRSF0.10N/A
+4.99%
Arianne Phosphate Inc
NEXOY14.580.33
+2.32%
Nexon Co Ltd.
LVMHF655.102.10
+0.32%
LVMH-Moet Hennessy Louis Vuitton
ASHTY255.220.72
+0.28%
Ashtead Group PLC
ASMVY29.38-0.49
-1.63%
ASMPT LTD.

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with PGEN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+8.73%
PGEN - MNKD
47%
Loosely correlated
+5.07%
NTLA - MNKD
44%
Loosely correlated
+0.83%
VCYT - MNKD
44%
Loosely correlated
+4.66%
LXRX - MNKD
42%
Loosely correlated
-1.23%
INSM - MNKD
40%
Loosely correlated
+1.48%
More